Standpoint Research Starts Gilead Sciences (GILD) at Buy
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $123.76 -1.35%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Standpoint Research initiated coverage on Gilead Sciences (NASDAQ: GILD) with a Buy rating and a price target of $110.00.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $82.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald post CFO Chat
- Noble Capital Starts Lands' End (LE) at Outperform
- Gilead Sciences: FDA accepts GILEAD application for once-weekly oral HIV prevention pill
Create E-mail Alert Related Categories
New CoverageRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
